CD4 and neoplasm: Consistent with changes in the immune state in the tumour tissues, NIL-IM-Lip+PD-1+L activated more CD4+ T cells, CD8+ T cells and NK cells and inhibited more Treg cells in the LNs (Fig. 8h, i).